Home › Pulmonary Hypertension › Minnesota
Pulmonary Hypertension clinical trials in Minnesota
8 studies for Pulmonary Hypertension are looking for participants at sites in Minnesota.
Cities in Minnesota
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Minnesota, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Mayo Clinic - Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Minneapolis Heart Institute, Minneapolis
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195Real World Observational Study of Sotatercept for Pulmonary Hypertension
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 6, 2026 · NCT06751082Pulmonary Hypertension in Left Heart Disease
- Mayo Clinic in Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT05935605CVD/PH and Voice Characteristics
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT07311044Pulmonary Hypertension Association Registry
- University of Minnesota Health, Minneapolis
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2025 · NCT04555161From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.